InvestorsHub Logo
Followers 9
Posts 499
Boards Moderated 0
Alias Born 03/28/2015

Re: None

Monday, 04/04/2022 12:19:11 PM

Monday, April 04, 2022 12:19:11 PM

Post# of 331511
Release #:812-227853-rl-1235735:
BioElectronics (OTC: BIEL) has taped our session on the Pitch. It will air on 4/14. Here is the link to share with shareholders to register to view it:

https://us02web.zoom.us/webinar/register/WN_KU-Q06BsQVydlavTw6_a1A?fbclid=IwAR04FnS6tLTWcliseR9YROFY7_HLZY8YbtKsaS2rprb5txhm-RT5E0LTg5E

EXPERT PANELISTS

Anthony Viscogliosi

Moderator, Expert Panelist

Mr. Viscogliosi was the first orthopedic industry analyst on Wall Street and executed more than 170 orthopedic deals with partners such as Johnson & Johnson, Stryker Corporation, Zimmer Holdings, and Abbott, among others. Past exits have generated in excess of $2.1 billion in capital returned to VB, co-investors, partners and lenders.

Audrey Beckman

Expert Panelist

Ms. Beckman is an independent Business Consultant with a long history in the medical device industry. Skilled in Orthopedics, Product Design, Marketing, Medical Training and Education, and Global Leadership of technical and non-technical teams. Executive roles included Product Development, Professional Education, and Quality Remediation.

Michael Sherman

Expert Panelist

Mr. Sherman has more than 30 year medical device industry experience. Twenty years orthopedic product development, 9 years in venture capital. During his career Mr. Sherman has been issued more than 120 patents and is recognized as an international leader in product development, marketing, regulatory, business development, executive leadership and venture capital.

Scott Bruder

Expert Panelist

An award-winning scientist and clinician, Dr. Bruder is equally comfortable in the laboratory, at the lectern, in the Boardroom or on Capitol Hill. A seasoned senior executive, University Professor, Board Member and former FDA Advisory Committee Member, Dr. Bruder delivers unique bench-to-bedside perspectives on unmet needs, development strategy and pathways from concept to commercialization.